{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:14:01Z","timestamp":1793146441929,"version":"4.5.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>A 59-year-old woman with an ulcerated right breast lesion was diagnosed with ER-positive invasive ductal carcinoma. Staging [\u00b9\u2078F]FDG PET\/CT revealed intense uptake in the breast, axillary nodes, a large hypermetabolic pulmonary mass, mediastinal lymphadenopathies, and bone lesions. Because of this metabolic pattern, [\u00b9\u2078F]FES PET\/CT was performed, demonstrating [\u00b9\u2078F]FES-avid bone metastases but no uptake in the lung mass. Biopsy confirmed a BRAF V600E-mutated lung adenocarcinoma. [\u00b9\u2078F]FES PET\/CT proved crucial in differentiating synchronous primary malignancies from metastatic spread and guiding targeted therapy with dabrafenib-trametinib.<\/jats:p>","DOI":"10.1097\/rlu.0000000000006386","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:07Z","timestamp":1771891207000},"page":"419-420","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["From One Cancer to Two"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5095-9805","authenticated-orcid":false,"given":"Anne-Claire","family":"Dupont","sequence":"first","affiliation":[{"name":"Nuclear Pharmacy Tours University Hospital, CHRU Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Farges","sequence":"additional","affiliation":[{"name":"Pneumology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Chapelle","sequence":"additional","affiliation":[{"name":"Nuclear Pharmacy Tours University Hospital, CHRU Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Cancel","sequence":"additional","affiliation":[{"name":"Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Joao Santiago","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, CHRU Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"R1-20260401","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fonc.2018.00427","article-title":"Second primary lung cancer after breast cancer: a population-based study of 6,269 women","volume":"8","author":"Wang","year":"2018","journal-title":"Front Oncol"},{"key":"R2-20260401","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1007\/s00259-024-06696-9","article-title":"Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET\/CT in no special type breast cancer: (endorsed by the ACR, ESSO, ESTRO, EUSOBI\/ESR, and EUSOMA)","volume":"51","author":"Vaz","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R3-20260401","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2967\/jnumed.123.265420","article-title":"Summary: Appropriate use criteria for estrogen receptor-targeted PET imaging with 16\u03b1-18F-fluoro-17\u03b2-fluoroestradiol","volume":"64","author":"Ulaner","year":"2023","journal-title":"J Nucl Med"},{"key":"R4-20260401","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2967\/jnumed.124.267913","article-title":"Impact of 18F-FES PET\/CT on clinical decisions in the management of recurrent or metastatic breast cancer","volume":"65","author":"Ryu","year":"2024","journal-title":"J Nucl Med"},{"key":"R5-20260401","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/RLU.0000000000005447","article-title":"Diagnostic accuracy of 18 F-FES PET\/CT for the detection of recurrent and metastatic breast cancer","volume":"50","author":"Shin","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R6-20260401","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/RLU.0000000000005465","article-title":"Upstaging of invasive lobular cancer with FES PET\/CT","volume":"50","author":"Rehman","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R7-20260401","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1097\/RLU.0000000000003382","article-title":"Detection of dural metastases before the onset of clinical symptoms by 16\u03b1-[18F]fluoro-17\u03b2-estradiol PET in a patient with estrogen receptor-positive breast cancer","volume":"46","author":"Boers","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R8-20260401","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1097\/RLU.0000000000004197","article-title":"18F-FES PET\/CT for characterization of brain and leptomeningeal metastasis in double primary cancer patient","volume":"47","author":"Lee","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:00:39Z","timestamp":1775077239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006386"}},"subtitle":["[\u00b9\u2078F]FES PET\/CT Redirected Diagnosis and Therapy in a Metastatic Breast Cancer Patient"],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006386","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2025-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}